Although limited by the number of genes tested, the results suggest that a positive crosstalk between Doxorubicin and TNF⍺ can be a general characteristic of different cell types and is at least in part p53-dependent, based on the results with a p53 null lung cancer cell line. The gene discussed is TP53; the disease is lung carcinoma.